Holen Sie sich die Stockscreener-App
1.97
1.55%
0.03
Schlusskurs vom Vortag:
$1.94
Offen:
$1.94
24-Stunden-Volumen:
484.52K
Relative Volume:
0.56
Marktkapitalisierung:
$127.63M
Einnahmen:
$212.69M
Nettoeinkommen (Verlust:
$-59.00M
KGV:
-2.1099
EPS:
-0.9337
Netto-Cashflow:
$-29.49M
1W Leistung:
-1.99%
1M Leistung:
+58.87%
6M Leistung:
-71.03%
1J Leistung:
-69.46%
1-Tages-Spanne:
$1.90
$2.0099
1-Wochen-Bereich:
$1.835
$2.2999
52-Wochen-Spanne:
$1.17
$7.78
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.97 | 125.68M | 212.69M | -59.00M | -29.49M | -0.9337 |
ABT
Abbott Laboratories
|
96.00 | 166.82B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 129.58B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 109.13B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 90.64B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.95B | 6.07B | 1.06B | 1.34B | 1.8063 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-12-31 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-08 | Herabstufung | Truist | Buy → Hold |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
| 2022-05-12 | Eingeleitet | BTIG Research | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Treace Medical Concepts (TMCI) CFO reports 11,547-share tax withholding - Stock Titan
Treace Medical Concepts, Inc. (TMCI) LawsuitInvestors Urged to Contact Levi & Korsinsky Before June 10, 2025 - The National Law Review
Wall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong Sell - MarketBeat
How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans - Yahoo Finance
Treace Medical Concepts (TMCI) price target increased by 12.28% to 4.08 - MSN
TMCI Faces Ownership Changes: Market Reactions Unclear - StocksToTrade
US Stocks Mixed; Dow Falls Over 100 Points - Sahm
Wall Street Zen Upgrades Treace Medical Concepts (NASDAQ:TMCI) to Sell - MarketBeat
Chart Watch: Will Treace Medical Concepts Inc outperform tech stocksMarket Performance Report & Verified Momentum Stock Ideas - baoquankhu1.vn
Treace Medical Concepts Announces Leadership Transition and Outlook - The Globe and Mail
Stifel maintains Hold on Treace Medical stock, $3 target unchanged By Investing.com - Investing.com India
Stifel maintains Hold on Treace Medical stock, $3 target unchanged - Investing.com
Market Overview: Will Treace Medical Concepts Inc stock hit new highs in YEARPortfolio Risk Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Treace Medical Concepts, Inc. Reports Q1 2026 Results and Financial Outlook in SEC Form 8-K Filing 10 - Minichart
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 earnings call transcript - MSN
Treace Medical Concepts Incpreliminary Q1 2026 revenue expected at $47.0 million-$47.2 millionSEC filing - marketscreener.com
Treace Medical (NASDAQ: TMCI) raises 2026 sales view as CCO departs - Stock Titan
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System - Ortho Spine News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) stock price, news, quote and history - Yahoo Finance UK
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
Treace Medical Concepts, Inc. Announces First Surgical Cases With The SuperBite Compression Screw System - marketscreener.com
Treace Announces First Surgical Cases with the SuperBite Compression Screw System - Bitget
New foot-and-ankle screw reaches first surgeries before Q3 launch - Stock Titan
Treace Medical Concepts (NASDAQ:TMCI) and PAVmed (NASDAQ:PAVM) Head-To-Head Survey - Defense World
Movement Recap: Is Treace Medical Concepts Inc forming bullish engulfing patterns2026 PostEarnings & Reliable Breakout Forecasts - baoquankhu1.vn
Update Report: How much upside does Treace Medical Concepts Inc haveWeekly Investment Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts (NASDAQ: TMCI) details 2026 virtual annual meeting, votes - Stock Titan
[ARS] TREACE MEDICAL CONCEPTS, INC. SEC Filing - Stock Titan
TMCI PE Ratio & Valuation, Is TMCI Overvalued - Intellectia AI
Treace Medical Concepts (TMCI) price target decreased by 10.94% to 3.63 - MSN
CFO at Treace Medical (TMCI) granted 100,000 performance stock units - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - ACCESS Newswire
Value Recap: How correlated is Treace Medical Concepts Inc to the S P5002026 AllTime Highs & Weekly High Return Stock Opportunities - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
TMCI Should I Buy - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect | NDAQ:TMCI | Press Release - Stockhouse
How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target Resets - Yahoo Finance
Quarterly Earnings: Is Treace Medical Concepts Inc gaining market shareWeekly Trading Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
CIBC Bancorp USA Inc. Acquires New Stake in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):